Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
Cell-cell proximity effects in multi-cell electroporation.

Biomicrofluidics

Henslee BE, Morss A, Hu X, Lafyatis GP, James Lee L.
PMID: 25332726
Biomicrofluidics. 2014 Aug 22;8(5):052002. doi: 10.1063/1.4893918. eCollection 2014 Sep.

We report a fundamental study of how the electropermeabilization of a cell is affected by nearby cells. Previous researchers studying electroporation of dense suspensions of cells have observed, both theoretically and experimentally, that such samples cannot be treated simply...

Cite
Henslee BE, Morss A, Hu X, et al. Cell-cell proximity effects in multi-cell electroporation. Biomicrofluidics. 2014;8(5):052002doi: 10.1063/1.4893918.
Henslee, B. E., Morss, A., Hu, X., Lafyatis, G. P., & James Lee, L. (2014). Cell-cell proximity effects in multi-cell electroporation. Biomicrofluidics, 8(5), 052002. https://doi.org/10.1063/1.4893918
Henslee, Brian E, et al. "Cell-cell proximity effects in multi-cell electroporation." Biomicrofluidics vol. 8,5 (2014): 052002. doi: https://doi.org/10.1063/1.4893918
Henslee BE, Morss A, Hu X, Lafyatis GP, James Lee L. Cell-cell proximity effects in multi-cell electroporation. Biomicrofluidics. 2014 Aug 22;8(5):052002. doi: 10.1063/1.4893918. eCollection 2014 Sep. PMID: 25332726; PMCID: PMC4189395.
Copy Download .nbib Format: NLM
Single-ion cyclotron resonance measurement of M(CO+)/M(N2+).

Physical review letters

Boyce KR, Cornell EA, Flanagan RW, Lafyatis GP, Pritchard DE, Weisskoff RM.
PMID: 10040641
Phys Rev Lett. 1989 Oct 16;63(16):1674-1677. doi: 10.1103/PhysRevLett.63.1674.

No abstract available.

Cite
Boyce KR, Cornell EA, Flanagan RW, et al. Single-ion cyclotron resonance measurement of M(CO+)/M(N2+). Phys Rev Lett. 1989;63(16):1674-1677doi: 10.1103/PhysRevLett.63.1674.
Boyce, K. R., Cornell, E. A., Flanagan, R. W., Lafyatis, G. P., Pritchard, D. E., & Weisskoff, R. M. (1989). Single-ion cyclotron resonance measurement of M(CO+)/M(N2+). Physical review letters, 63(16), 1674-1677. https://doi.org/10.1103/PhysRevLett.63.1674
Boyce, et al. "Single-ion cyclotron resonance measurement of M(CO+)/M(N2+)." Physical review letters vol. 63,16 (1989): 1674-1677. doi: https://doi.org/10.1103/PhysRevLett.63.1674
Boyce KR, Cornell EA, Flanagan RW, Lafyatis GP, Pritchard DE, Weisskoff RM. Single-ion cyclotron resonance measurement of M(CO+)/M(N2+). Phys Rev Lett. 1989 Oct 16;63(16):1674-1677. doi: 10.1103/PhysRevLett.63.1674. PMID: 10040641.
Copy Download .nbib Format: NLM
Note: Electroplating process for connectorizing superconducting NbTi cables.

The Review of scientific instruments

DeBry K, Lafyatis G.
PMID: 30068139
Rev Sci Instrum. 2018 Jul;89(7):076108. doi: 10.1063/1.5030431.

Experiments done at cryogenic temperatures below the 4.2 K temperature of liquid helium frequently require superconducting coaxial cables to efficiently transmit high-frequency signals while minimizing heat transfer to the experiment's cold stage. These cables are often made of niobium-titanium...

Cite
DeBry K, Lafyatis G. Note: Electroplating process for connectorizing superconducting NbTi cables. Rev Sci Instrum. 2018;89(7):076108doi: 10.1063/1.5030431.
DeBry, K., & Lafyatis, G. (2018). Note: Electroplating process for connectorizing superconducting NbTi cables. The Review of scientific instruments, 89(7), 076108. https://doi.org/10.1063/1.5030431
DeBry, Kyle, and Lafyatis, Gregory. "Note: Electroplating process for connectorizing superconducting NbTi cables." The Review of scientific instruments vol. 89,7 (2018): 076108. doi: https://doi.org/10.1063/1.5030431
DeBry K, Lafyatis G. Note: Electroplating process for connectorizing superconducting NbTi cables. Rev Sci Instrum. 2018 Jul;89(7):076108. doi: 10.1063/1.5030431. PMID: 30068139.
Copy Download .nbib Format: NLM
Measurement of electron-impact excitation in boronlike carbon.

Physical review. A, General physics

Kohl JL, Lafyatis GP.
PMID: 9898655
Phys Rev A Gen Phys. 1987 Jul 01;36(1):59-65. doi: 10.1103/physreva.36.59.

No abstract available.

Cite
Kohl JL, Lafyatis GP. Measurement of electron-impact excitation in boronlike carbon. Phys Rev A Gen Phys. 1987;36(1):59-65doi: 10.1103/physreva.36.59.
Kohl, J. L., & Lafyatis, G. P. (1987). Measurement of electron-impact excitation in boronlike carbon. Physical review. A, General physics, 36(1), 59-65. https://doi.org/10.1103/physreva.36.59
Kohl, and Lafyatis. "Measurement of electron-impact excitation in boronlike carbon." Physical review. A, General physics vol. 36,1 (1987): 59-65. doi: https://doi.org/10.1103/physreva.36.59
Kohl JL, Lafyatis GP. Measurement of electron-impact excitation in boronlike carbon. Phys Rev A Gen Phys. 1987 Jul 01;36(1):59-65. doi: 10.1103/physreva.36.59. PMID: 9898655.
Copy Download .nbib Format: NLM
A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis.

Journal of scleroderma and related disorders

Kong K, Koontz D, Morse C, Roth E, Domsic RT, Simon MA, Stratton E, Buchholz C, Tobin-Finch K, Simms R, George MP, Hassoun PM, Farber H, Lafyatis R.
PMID: 35005243
J Scleroderma Relat Disord. 2021 Oct 01;6(3):242-246. doi: 10.1177/23971983211016196. Epub 2021 May 28.

INTRODUCTION: Given the poor treatment options for pulmonary arterial hypertension associated systemic sclerosis (SSc-PAH) patients, we sought to determine clinical safety and efficacy of Dimethylfumarate (DMF), an Nrf2 agonist, and the effects on biomarkers of oxidative stress on SSc-PAH...

Cite
Kong K, Koontz D, Morse C, et al. A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis. J Scleroderma Relat Disord. 2021;6(3):242-246doi: 10.1177/23971983211016196.
Kong, K., Koontz, D., Morse, C., Roth, E., Domsic, R. T., Simon, M. A., Stratton, E., Buchholz, C., Tobin-Finch, K., Simms, R., George, M. P., Hassoun, P. M., Farber, H., & Lafyatis, R. (2021). A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis. Journal of scleroderma and related disorders, 6(3), 242-246. https://doi.org/10.1177/23971983211016196
Kong, Kristi, et al. "A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis." Journal of scleroderma and related disorders vol. 6,3 (2021): 242-246. doi: https://doi.org/10.1177/23971983211016196
Kong K, Koontz D, Morse C, Roth E, Domsic RT, Simon MA, Stratton E, Buchholz C, Tobin-Finch K, Simms R, George MP, Hassoun PM, Farber H, Lafyatis R. A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis. J Scleroderma Relat Disord. 2021 Oct 01;6(3):242-246. doi: 10.1177/23971983211016196. Epub 2021 May 28. PMID: 35005243; PMCID: PMC8741170.
Copy Download .nbib Format: NLM
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.

Nature communications

Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL.
PMID: 34921143
Nat Commun. 2021 Dec 17;12(1):7338. doi: 10.1038/s41467-021-27619-4.

Head and neck squamous cell carcinoma (HNSCC) is characterized by complex relations between stromal, epithelial, and immune cells within the tumor microenvironment (TME). To enable the development of more efficacious therapies, we aim to study the heterogeneity, signatures of...

Cite
Kürten CHL, Kulkarni A, Cillo AR, et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021;12(1):7338doi: 10.1038/s41467-021-27619-4.
Kürten, C. H. L., Kulkarni, A., Cillo, A. R., Santos, P. M., Roble, A. K., Onkar, S., Reeder, C., Lang, S., Chen, X., Duvvuri, U., Kim, S., Liu, A., Tabib, T., Lafyatis, R., Feng, J., Gao, S. J., Bruno, T. C., Vignali, D. A. A., Lu, X., Bao, R., Vujanovic, L., & Ferris, R. L. (2021). Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nature communications, 12(1), 7338. https://doi.org/10.1038/s41467-021-27619-4
Kürten, Cornelius H L, et al. "Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing." Nature communications vol. 12,1 (2021): 7338. doi: https://doi.org/10.1038/s41467-021-27619-4
Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021 Dec 17;12(1):7338. doi: 10.1038/s41467-021-27619-4. PMID: 34921143.
Copy Download .nbib Format: NLM
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.

The Lancet. Rheumatology

Chung L, Spino C, McLain R, Johnson SR, Denton CP, Molitor JA, Steen VD, Lafyatis R, Simms RW, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Sandorfi N, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Allanore Y, Matucci-Cerinic M, Whitfield ML, Distler O, Singer O, Young A, Nagaraja V, Fox DA, Furst DE, Khanna D.
PMID: 34966900
Lancet Rheumatol. 2020 Dec;2(12):e743-e753. doi: 10.1016/s2665-9913(20)30237-x. Epub 2020 Oct 19.

BACKGROUND: Abatacept was well tolerated by patients with early diffuse cutaneous systemic sclerosis in a phase 2, double-blind randomised trial, with potential efficacy at 12 months. We report here the results of an open-label extension for 6 months.METHODS: Patients...

Cite
Chung L, Spino C, McLain R, et al. Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. Lancet Rheumatol. 2020;2(12):e743-e753doi: 10.1016/s2665-9913(20)30237-x.
Chung, L., Spino, C., McLain, R., Johnson, S. R., Denton, C. P., Molitor, J. A., Steen, V. D., Lafyatis, R., Simms, R. W., Kafaja, S., Frech, T. M., Hsu, V., Domsic, R. T., Pope, J. E., Gordon, J. K., Mayes, M. D., Sandorfi, N., Hant, F. N., Bernstein, E. J., Chatterjee, S., Castelino, F. V., Ajam, A., Allanore, Y., Matucci-Cerinic, M., Whitfield, M. L., Distler, O., Singer, O., Young, A., Nagaraja, V., Fox, D. A., Furst, D. E., & Khanna, D. (2020). Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. The Lancet. Rheumatology, 2(12), e743-e753. https://doi.org/10.1016/s2665-9913(20)30237-x
Chung, Lorinda, et al. "Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial." The Lancet. Rheumatology vol. 2,12 (2020): e743-e753. doi: https://doi.org/10.1016/s2665-9913(20)30237-x
Chung L, Spino C, McLain R, Johnson SR, Denton CP, Molitor JA, Steen VD, Lafyatis R, Simms RW, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Sandorfi N, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Allanore Y, Matucci-Cerinic M, Whitfield ML, Distler O, Singer O, Young A, Nagaraja V, Fox DA, Furst DE, Khanna D. Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. Lancet Rheumatol. 2020 Dec;2(12):e743-e753. doi: 10.1016/s2665-9913(20)30237-x. Epub 2020 Oct 19. PMID: 34966900; PMCID: PMC8713509.
Copy Download .nbib Format: NLM
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.

Nature communications

Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL.
PMID: 34921143
Nat Commun. 2021 Dec 17;12(1):7338. doi: 10.1038/s41467-021-27619-4.

Head and neck squamous cell carcinoma (HNSCC) is characterized by complex relations between stromal, epithelial, and immune cells within the tumor microenvironment (TME). To enable the development of more efficacious therapies, we aim to study the heterogeneity, signatures of...

Cite
Kürten CHL, Kulkarni A, Cillo AR, et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021;12(1):7338doi: 10.1038/s41467-021-27619-4.
Kürten, C. H. L., Kulkarni, A., Cillo, A. R., Santos, P. M., Roble, A. K., Onkar, S., Reeder, C., Lang, S., Chen, X., Duvvuri, U., Kim, S., Liu, A., Tabib, T., Lafyatis, R., Feng, J., Gao, S. J., Bruno, T. C., Vignali, D. A. A., Lu, X., Bao, R., Vujanovic, L., & Ferris, R. L. (2021). Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nature communications, 12(1), 7338. https://doi.org/10.1038/s41467-021-27619-4
Kürten, Cornelius H L, et al. "Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing." Nature communications vol. 12,1 (2021): 7338. doi: https://doi.org/10.1038/s41467-021-27619-4
Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021 Dec 17;12(1):7338. doi: 10.1038/s41467-021-27619-4. PMID: 34921143.
Copy Download .nbib Format: NLM
Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4.

The Journal of investigative dermatology

Jussila AR, Zhang B, Caves E, Kirti S, Steele M, Hamburg-Shields E, Lydon J, Ying Y, Lafyatis R, Rajagopalan S, Horsley V, Atit RP.
PMID: 34808238
J Invest Dermatol. 2021 Nov 20; doi: 10.1016/j.jid.2021.10.025. Epub 2021 Nov 20.

Fibrosis is the life-threatening, excessive accumulation of the extracellular matrix and is sometimes associated with a loss of lipid-filled cells in the skin and other organs. Understanding the mechanisms of fibrosis and associated lipodystrophy and their reversal may reveal...

Cite
Jussila AR, Zhang B, Caves E, et al. Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4. J Invest Dermatol. 2021;doi: 10.1016/j.jid.2021.10.025.
Jussila, A. R., Zhang, B., Caves, E., Kirti, S., Steele, M., Hamburg-Shields, E., Lydon, J., Ying, Y., Lafyatis, R., Rajagopalan, S., Horsley, V., & Atit, R. P. (2021). Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4. The Journal of investigative dermatology, . https://doi.org/10.1016/j.jid.2021.10.025
Jussila, Anna R, et al. "Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4." The Journal of investigative dermatology vol. (2021). doi: https://doi.org/10.1016/j.jid.2021.10.025
Jussila AR, Zhang B, Caves E, Kirti S, Steele M, Hamburg-Shields E, Lydon J, Ying Y, Lafyatis R, Rajagopalan S, Horsley V, Atit RP. Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4. J Invest Dermatol. 2021 Nov 20; doi: 10.1016/j.jid.2021.10.025. Epub 2021 Nov 20. PMID: 34808238.
Copy Download .nbib Format: NLM
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.

Nature communications

Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL.
PMID: 34921143
Nat Commun. 2021 Dec 17;12(1):7338. doi: 10.1038/s41467-021-27619-4.

Head and neck squamous cell carcinoma (HNSCC) is characterized by complex relations between stromal, epithelial, and immune cells within the tumor microenvironment (TME). To enable the development of more efficacious therapies, we aim to study the heterogeneity, signatures of...

Cite
Kürten CHL, Kulkarni A, Cillo AR, et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021;12(1):7338doi: 10.1038/s41467-021-27619-4.
Kürten, C. H. L., Kulkarni, A., Cillo, A. R., Santos, P. M., Roble, A. K., Onkar, S., Reeder, C., Lang, S., Chen, X., Duvvuri, U., Kim, S., Liu, A., Tabib, T., Lafyatis, R., Feng, J., Gao, S. J., Bruno, T. C., Vignali, D. A. A., Lu, X., Bao, R., Vujanovic, L., & Ferris, R. L. (2021). Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nature communications, 12(1), 7338. https://doi.org/10.1038/s41467-021-27619-4
Kürten, Cornelius H L, et al. "Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing." Nature communications vol. 12,1 (2021): 7338. doi: https://doi.org/10.1038/s41467-021-27619-4
Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021 Dec 17;12(1):7338. doi: 10.1038/s41467-021-27619-4. PMID: 34921143.
Copy Download .nbib Format: NLM
Correction to: Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma.

Arthritis research & therapy

Mirizio E, Tabib T, Wang X, Chen W, Liu C, Lafyatis R, Jacobe H, Torok KS.
PMID: 33823906
Arthritis Res Ther. 2021 Apr 06;23(1):101. doi: 10.1186/s13075-021-02490-2.

No abstract available.

Cite
Mirizio E, Tabib T, Wang X, et al. Correction to: Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma. Arthritis Res Ther. 2021;23(1):101doi: 10.1186/s13075-021-02490-2.
Mirizio, E., Tabib, T., Wang, X., Chen, W., Liu, C., Lafyatis, R., Jacobe, H., & Torok, K. S. (2021). Correction to: Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma. Arthritis research & therapy, 23(1), 101. https://doi.org/10.1186/s13075-021-02490-2
Mirizio, Emily, et al. "Correction to: Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma." Arthritis research & therapy vol. 23,1 (2021): 101. doi: https://doi.org/10.1186/s13075-021-02490-2
Mirizio E, Tabib T, Wang X, Chen W, Liu C, Lafyatis R, Jacobe H, Torok KS. Correction to: Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma. Arthritis Res Ther. 2021 Apr 06;23(1):101. doi: 10.1186/s13075-021-02490-2. PMID: 33823906; PMCID: PMC8022423.
Copy Download .nbib Format: NLM
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design.

Rheumatology (Oxford, England)

Domsic RT, Gao S, Laffoon M, Wisniewski S, Zhang Y, Steen V, Lafyatis R, Medsger TA.
PMID: 33506859
Rheumatology (Oxford). 2021 Oct 02;60(10):4662-4670. doi: 10.1093/rheumatology/keab075.

OBJECTIVES: Clinical trials in early diffuse cutaneous systemic sclerosis (SSc) using the modified Rodnan skin score (mRSS) as the primary outcome measure have most often been negative. We wanted to assess how the definition of disease onset (first SSc...

Cite
Domsic RT, Gao S, Laffoon M, et al. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford). 2021;60(10):4662-4670doi: 10.1093/rheumatology/keab075.
Domsic, R. T., Gao, S., Laffoon, M., Wisniewski, S., Zhang, Y., Steen, V., Lafyatis, R., & Medsger, T. A. (2021). Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford, England), 60(10), 4662-4670. https://doi.org/10.1093/rheumatology/keab075
Domsic, Robyn T, et al. "Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design." Rheumatology (Oxford, England) vol. 60,10 (2021): 4662-4670. doi: https://doi.org/10.1093/rheumatology/keab075
Domsic RT, Gao S, Laffoon M, Wisniewski S, Zhang Y, Steen V, Lafyatis R, Medsger TA. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford). 2021 Oct 02;60(10):4662-4670. doi: 10.1093/rheumatology/keab075. PMID: 33506859.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries